DEF 14A
DISCOVERY LABORATORIES INC DEF 14A 6-11-2013
- Company
- WINDTREE THERAPEUTICS INC /DE/
- Filed
- April 30, 2013
- Period of Report
- June 11, 2013
- Accession Number
- 0001140361-13-017801
A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →